You searched for - Page 57 of 141 - KFF Health News

States — And 9M Kids — ‘In A Bind’ As Congress Dawdles On CHIP Funding

By Ashley Lopez, KUT and Selena Simmons-Duffin, NPR December 4, 2017 KFF Health News Original

Congress let funding for the Children’s Health Insurance Program expire in September, and despite bipartisan support for the program, states are facing the specter of having to prepare to wind down their programs.

Facebook Live: Trump Ends Payments For Cost-Sharing Reductions. What’s Next?

October 13, 2017 KFF Health News Original

In this Facebook Live chat, KHN’s Jay Hancock answers questions about President Donald Trump’s announcement that he will end federal payments for the Affordable Care Act’s cost-sharing reductions.

From Retirement To The Front Lines Of Hepatitis C Treatment

By Julio Ochoa, WUSF January 5, 2018 KFF Health News Original

This doctor came out of retirement with the goal of treating every patient at high risk for hepatitis C he encounters. The problem is finding them.

Meningitis B Vaccine’s High Price Poses A Health Care Conundrum For College-Bound

By Shefali Luthra September 8, 2017 KFF Health News Original

This immunization may mark a shift among some vaccine makers to higher-priced, “niche” preventives that protect against very specific and sometimes rare illnesses.

After Months In Limbo For Children’s Health Insurance, Huge Relief Over Deal

By Selena Simmons-Duffin, NPR January 25, 2018 KFF Health News Original

The Children’s Health Insurance Program drew bipartisan support for two decades. After brinkmanship over the federal budget, an agreement to end the shutdown has assured CHIP funding for six years.

Celgene Expected To Rake In $15B This Year With Strength Of Its Blockbuster Cancer Drug

July 27, 2018 Morning Briefing

But the company is on the look-out for its next blockbuster as Revlimid will face market competition in coming years. Meanwhile, advocate groups ask for insurance commissioners will investigate the growing use of copay accumulators.

Bill Of The Month: For Toenail Fungus, A $1,500 Prescription

By Shefali Luthra March 16, 2018 KFF Health News Original

How a prescription wiped out one woman’s health reimbursement account, raising questions about prescription drug price tags and about how health care professionals deal (or don’t) with medical costs.

Money For Health Law Navigators Slashed — Except Where It’s Not

By Alex Olgin, WFAE October 30, 2017 KFF Health News Original

Two states, North and South Carolina, have very different outlooks since the Trump administration cut funding for the people who help others sign up for health insurance.

Putting Money Where Its Mouthpiece Is: Calif. Outspends U.S. To Market Obamacare

By Ana B. Ibarra and Carmen Heredia Rodriguez November 27, 2017 KFF Health News Original

The state insurance exchange is committing nearly five times more money than the federal government on ads urging people to sign up for health insurance, reflecting conflicting attitudes toward the Affordable Care Act.

Defending Against This Season’s Deadly Flu: 5 Things To Know Now

By Barbara Feder Ostrov January 9, 2018 KFF Health News Original

A particularly nasty flu is widespread in 46 states. Nationally, at least 106 people have died from the infectious disease.

Appeals Court Delivers Latest Blow To Hospitals By Rejecting Challenge To 340B Changes

July 18, 2018 Morning Briefing

The program helps hospitals cover charity costs related to prescriptions drugs. Last July, the Trump administration proposed slashing its higher reimbursement for the drugs by about 27 percent. A judge ruled that the hospitals had challenged the changes prematurely as none of them had taken effect yet, and the court of appeals on Tuesday affirmed the decision.

States Strive To Curb Costs For A Crucial — But Exorbitant — Hemophilia Treatment

By Barbara Feder Ostrov Photos by Heidi de Marco March 6, 2018 KFF Health News Original

Saving the lives of people with the bleeding disorder can require high doses of expensive blood-clotting factor. Taxpayers foot much of the bill as manufacturers profit enormously.

Azar Warns Pharma That Administration Will Be ‘Turning On The Pressure’ As He Defends President’s Drug Plan

May 15, 2018 Morning Briefing

HHS Secretary Alex Azar blasted a long-standing Democratic idea for Medicare to negotiate drug prices, saying it would deny access to medicines “through rationing or setting prices,” which he called a “move toward socialized medicine.” However, Azar did promise to upend Medicare Part B’s payment structure.

10 Ways Medicaid Affects Us All

October 5, 2017 KFF Health News Original

Medicaid was created in 1965 as a program for the poor. Today, it helps 74 million people — more than 1 of every 5 people in the U.S. You or someone you know likely benefits.

Perspectives: Administration’s Proposition On 340B Drug Program Is Equivalent Of An Own-Goal In Soccer

July 11, 2018 Morning Briefing

Read recent commentaries about drug-cost issues.

Money-Saving Offer For Medicare’s Late Enrollees Is Expiring. Can They Buy Time?

By Susan Jaffe September 22, 2017 KFF Health News Original

Sept. 30 marks the end of Medicare’s temporary offer to waive penalties for certain late Medicare enrollees with Affordable Care Act insurance coverage.

Facebook Live: It’s ACA Sign Up Season. Here’s What you Need To Know This Year.

November 2, 2017 KFF Health News Original

In this Facebook Live chat, KHN’s Julie Appleby answers questions about what’s changed for 2018 open enrollment.

Tending To Patients As Her New Home Burns

By April Dembosky, KQED October 16, 2017 KFF Health News Original

ICU nurse Julayne Smithson had only a few minutes to grab some things from her recently purchased home a block from the Santa Rosa hospital. Then she rushed back to help evacuate patients and has scarcely stopped working since.

Heart Device Failure: Medicare Spent $1.5B Over 10 Years To Replace Defective Implants

By Fred Schulte and Christina Jewett October 2, 2017 KFF Health News Original

The inspector general at Health and Human Services says defective pacemakers or defibrillators had to be replaced from 2005 through 2014, costing Medicare $1.5 billion.

Of ‘Miracles’ And Money: Why Hemophilia Drugs Are So Expensive

By Jenny Gold Photos by Heidi de Marco March 8, 2018 KFF Health News Original

The market is flooded with 28 different medications for just 20,000 patients with the hereditary bleeding disorder. Yet intense competition hasn’t worked to bring costs down. Sales amount to $4.6 billion annually in the U.S.

Filter Results

More From KFF Health News